We are live on ! Find out more
GTBP icon

GT Biopharma
GTBP

42 hedge funds and large institutions have $657K invested in GT Biopharma in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more capital invested

Capital invested by funds: $374K → $657K (+$283K)

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

11% more funds holding

Funds holding: 38 → 42 (+4)

0.57% more ownership

Funds ownership: 4.54% → 5.11% (+0.57%)

Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
7
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Geode Capital Management
Geode Capital Management
Massachusetts
+$150K
2
AAP
Arax Advisory Partners
Colorado
+$51.1K
3
UBS Group
UBS Group
Switzerland
+$25.1K
4
I
INVST
Indiana
+$12.8K
5
KP
Keel Point
Alabama
+$11.3K

Top Sellers

1
SRL
Scientech Research LLC
New Jersey
-$43K
2
Jane Street
Jane Street
New York
-$20.4K
3
HF
HRT Financial
New York
-$9K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$8.51K
5
Citadel Advisors
Citadel Advisors
Florida
-$7.96K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Parsons Capital Management
Rhode Island
$4.45K – – –
HSA
27
HBK Sorce Advisory
Pennsylvania
$3.75K – – –
BlackRock
28
BlackRock
New York
$3.43K -$1 -1 -0%
AF
29
Allworth Financial
California
$1.84K +$2.46K +4,500 +450,000%
NFSG
30
Newbridge Financial Services Group
Florida
$1.53K – – –
FFA
31
Farther Finance Advisors
California
$1.23K – – –
MPWT
32
MassMutual Private Wealth & Trust
Connecticut
$1.22K +$1.64K +3,000 New
WFA
33
West Financial Advisors
Iowa
$1.02K +$1.36K +2,500 New
TRCT
34
Tower Research Capital (TRC)
New York
$693 -$2 -3 -0.2%
TCM
35
Triumph Capital Management
Colorado
$675 – – –
SHIM
36
Stone House Investment Management
Pennsylvania
$510 +$683 +1,251 New
Fidelity Investments
37
Fidelity Investments
Massachusetts
$408 +$546 +1,000 New
HNB
38
Hilltop National Bank
Wyoming
$41 +$55 +100 New
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$7 – – –
SRL
40
Scientech Research LLC
New Jersey
– -$43K -54,745 Closed
Jane Street
41
Jane Street
New York
– -$20.4K -26,016 Closed
HF
42
HRT Financial
New York
– -$9K -11,767 Closed
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
– -$8.51K -10,834 Closed
ASN
44
Advisory Services Network
Georgia
– -$7.85K -10,000 Closed
WWM
45
Wolff Wiese Magana
California
– -$3.93K -5,000 Closed
Citigroup
46
Citigroup
New York
– -$2.18K -2,781 Closed
SC
47
Swan Capital
Florida
– -$785 -1,000 Closed
SWM
48
Spire Wealth Management
Virginia
– -$785 -994 Closed
Bank of America
49
Bank of America
North Carolina
– -$19 -24 Closed
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
– +$69 +126 New
1
2

GTBP Hedge Fund Activity: Q1 2026 in Review

42 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in GT Biopharma (GTBP) for Q1 2026, worth a combined $657K — up 76% from $374K a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new GTBP positions and 10 closed out — a net gain of 5 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $150K. The largest seller was Scientech Research LLC, exiting entirely with an estimated $43K sold.

  • 42 institutional investors held GT Biopharma (GTBP) as of Q1 2026, up from 38 in Q4 2025.
  • Funds reported $657K of GT Biopharma stock for Q1 2026, up 76% quarter-over-quarter.
  • 15 funds opened new GT Biopharma positions in Q1 2026 and 10 closed out, a net change of +5 holders.
  • The largest GT Biopharma buyer in Q1 2026 was Geode Capital Management, an estimated $150K added.
  • The largest GT Biopharma seller in Q1 2026 was Scientech Research LLC, an estimated $43K sold.

Based on aggregated 13F filings for Q1 2026.